<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="343307">
  <stage>Registered</stage>
  <submitdate>2/09/2011</submitdate>
  <approvaldate>2/09/2011</approvaldate>
  <actrnumber>ACTRN12611000947909</actrnumber>
  <trial_identification>
    <studytitle>Randomised controlled trial of an internet intervention to reduce psychostimulant use</studytitle>
    <scientifictitle>Brief online intervention aimed at psychostimulant users, measuring change in psychostimulant use.</scientifictitle>
    <utrn>U1111-1123-5610</utrn>
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Psychostimulant use</healthcondition>
    <conditioncode>
      <conditioncode1>Mental Health</conditioncode1>
      <conditioncode2>Addiction</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>The intervention condition involves an online intervention consisting of motivational interviewing and cognitive behavioural therapy.
The intervention is three modules (one to be completed each week). Each module takes approximately 30 minutes. There is no additional routine support (information for external crisis support e.g. help lines will be listed).</interventions>
    <comparator>A waitlist control group. This group receives no treatment during the trial although it is provided with access to the intervention after the completion of the study at 6 months post baseline.</comparator>
    <control>Active</control>
    <interventioncode>Behaviour</interventioncode>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>WHO ASSIST Amphetamine Type Stimulant scores.</outcome>
      <timepoint>Baseline, 3 and 6-months after randomisation.</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Mean help-seeking intention / behaviour scores (Wilson, Deane, &amp; Ciarrochi, 2005).</outcome>
      <timepoint>Baseline, 3 and  6 months after randomisation.</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Percentage of participants who move from Precontemplation to Contemplation/Action stage, or from Contemplation to Action stage, based on Readiness to Change questionnaire scores (Rollnick, Heather, Gold, &amp; Hall, 1992).</outcome>
      <timepoint>Baseline, 3 and 6 months after randomisation</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Mean K10 scores (psychological distress).</outcome>
      <timepoint>Baseline, 3 and 6 months after randomisation.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Poly drug use (defined as the sum of ASSIST classes of drugs reported).</outcome>
      <timepoint>Baseline, 3 and 6 months after randomisation.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Days out of Role scores (Kessler &amp; Frank, 1997).</outcome>
      <timepoint>Baseline, 3 and 6 months after randomisation.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Mean EUROHIS Quality of Life scores (Schmidt, Muhlan, &amp; Power, 2005).</outcome>
      <timepoint>Baseline, 3 and 6 months after randomisation</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Descriptive measures of completion and adherence (active group only) assessed as i) completion of post test surveys, ii) number of modules completed iii) satisfaction with intervention.
Satisfaction will be measured with the first 8 items from the client satisfaction questionnaire (4 point likert scales)</outcome>
      <timepoint>3 months after randomisation.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Use of illicit psychostimulants (e.g. meth/amphetamine, ecstasy, non-medical use of prescription psychostimulants) in the last three months; willing to be randomised to one of two study groups; access to the Internet; access to e-mail; informed consent</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Currently receiving pharmacotherapy (e.g. methadone, naltrexone, buprenorphine) for any substance use disorder except nicotine replacement therapy; currently receiving any treatment for psychostimulant abuse/dependence; current or past diagnosis of schizophrenia or bipolar disorder.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Central randomisation by computer</concealment>
    <sequence>Permuted block randomisation</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/10/2011</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>160</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>The Australian National University</primarysponsorname>
    <primarysponsoraddress>The Australian National University
Canberra ACT 0200
Australia</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>Commonwealth of Australia Department of Health and Ageing</fundingname>
      <fundingaddress>Sirius Building, Furzer Street, Woden Town Centre
Canberra ACT 2601, Australia</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
    <othercollaborator>
      <othercollaboratortype>University</othercollaboratortype>
      <othercollaboratorname>The University of New South Wales</othercollaboratorname>
      <othercollaboratoraddress>The University of New South Wales
Sydney
NSW 2052
Australia</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Many Psychostimulant users do not seek treatment for their drug use.  Several barriers to treatment have been identified including confidentiality: stigma, socio-demographic factors: employment (particularly full-time employment), gender, and immigrant status, which suggest both physical and cultural barriers to accessing treatment.
This study will evaluate the effectiveness of an on-line intervention which uses cognitive behavioural therapy and motivational techniques designed to reduce harmful psychostimulant use.</summary>
    <trialwebsite />
    <publication>Tait, R.J., McKetin, R., Kay-Lambkin, F., Geddes, J., Bennett, K., Griffiths K., Christensen, H. breakingtheice: Protocol for an online intervention for psychostimulant misuse. (Poster presentation) International Society for Research on Internet Interventions, Sydney 2011.</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>The Australian Nationa University HREC</ethicname>
      <ethicaddress>Research Office
Lower Ground Floor 
Chancelry 10B 
East Road
Australian National University
Acton ACT 0200</ethicaddress>
      <ethicapprovaldate>26/08/2011</ethicapprovaldate>
      <hrec>2011/358</hrec>
      <ethicsubmitdate>12/08/2011</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Robert Tait</name>
      <address>Centre for Mental Health Research
Building 63
The Australian National University
Canberra ACT 0200</address>
      <phone>+61 2 6125 9106</phone>
      <fax>+61 2 6125 0733</fax>
      <email>robert.tait@anu.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Robert Tait</name>
      <address>Centre for Mental Health Research
Building 63
The Australian National University
Canberra ACT 0200</address>
      <phone>+61 2 6125 9106</phone>
      <fax>+61 2 6125 0733</fax>
      <email>robert.tait@anu.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Adam Garrick</name>
      <address>Centre for Mental Health Research
Building 63
The Australian National University
Canberra ACT 0200</address>
      <phone>+61 2 6125 6825</phone>
      <fax>+61 2 6125 0733</fax>
      <email>adam.garrick@anu.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>